No results for ‘’
Omaxe Ltd
NSE: OMAXE BSE: 532880
â‚ą74.85
(0.21%)
Mon, 15 Jun 2026, 05:13 pm
Market Cap (in Cr)1357.3
PE Ratio0
Dividend0
Finance
Real Estate Development
24.5KOmaxe Analysis
dividend
- Omaxe is not paying a notable dividend for India, therefore no need to check if the payments are increasing.
- No need to calculate the sustainability of Omaxe's dividends as it is not paying a notable one for India.
- Omaxe is not paying a notable dividend for India, therefore no need to check if the payments are stable.
- Omaxe's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Omaxe's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Omaxe is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Omaxe is profitable, therefore cash runway is not a concern.
- Omaxe is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (70%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 9x debt.
- Omaxe's cash and other short term assets cover its long term commitments.
- Omaxe earns more interest than it pays, coverage of interest payments is not a concern.
- The level of debt compared to net worth has increased over the past 5 years (29.1% vs 58.4% today).
- Omaxe's level of debt (58.4%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
- Mohit's remuneration is lower than average for companies of similar size in India.
- The average tenure for the Omaxe board of directors is less than 3 years, this suggests a new board.
- Mohit's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.
- The average tenure for the Omaxe management team is less than 2 years, this suggests a new team.
misc
- Omaxe is not covered by any analysts.
- Omaxe has significant price volatility in the past 3 months.
past
- Omaxe's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Omaxe's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Omaxe used its assets less efficiently than the IN Real Estate industry average last year based on Return on Assets.
- Omaxe's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Omaxe has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Omaxe's 1-year earnings growth is negative, it can't be compared to the IN Real Estate industry average.
value
- Omaxe's share price is below the future cash flow value, and at a moderate discount (> 20%).
- 532880 outperformed the Real Estate industry which returned -24.3% over the past year.
- 532880 outperformed the Market in India which returned -14.5% over the past year.
- BSE:532880 is up 21.9% outperforming the Real Estate industry which returned 13.9% over the past month.
- BSE:532880 is up 21.9% outperforming the market in India which returned 8% over the past month.
- Omaxe's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- Omaxe is overvalued based on assets compared to the IN Real Estate industry average.
- Omaxe is overvalued based on earnings compared to the IN Real Estate industry average.
- Omaxe is overvalued based on earnings compared to the India market.